Jinxin Fertility cashes in on sector novelty for HK$3bn IPO
China’s Jinxin Fertility Group has raised HK$2.99bn ($381.9m) from its Hong Kong listing after riding a wave of investor demand for healthcare stocks.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: